SynthesisFrontiers in immunology2026

Real-world outcomes of atezolizumab-bevacizumab and durvalumab-tremelimumab in unresectable hepatocellular carcinoma: a systematic review with covariate-adjusted meta-regression and exploratory machine learning analysis.

Jongin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.